Clinical Trial Update: A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous Chemotherapy [Phase 2]

View source ↗

Summary

A Phase II study evaluating fruquintinib in combination with capecitabine as first-line therapy for advanced/metastatic colorectal cancer unsuitable for intrave…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Unresectable Metastatic Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Fruquintinib (fruquintinib)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Unresectable Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN